TrialPanorama/TrialPanorama-database huggingface dataset:
Study 27009022 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 8782752 — Surrogate Endpoint (SUR): Blood pressure
Study 28988172 — Surrogate Endpoint (SUR): Blood pressure
Study 12850192 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 1473919 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 1473919 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 27120329 — Surrogate Endpoint (SUR): Blood pressure
Study 17662528 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 17662528 — Safety Biomarker (SAF): BDNF
Study 11468025 — Predictive Biomarker (PRD): SKAP2 mRNA
Genes: SKAP2; PRAP; RA70; SAPS; SCAP2; SKAP55R
Study 11468025 — Predictive Biomarker (PRD): CTRC mRNA
Genes: CTRC; CLCR
Study 11468025 — Surrogate Endpoint (SUR): Serum creatinine
Study 24279445 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 21167338 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 31974286 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 31547827 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 25712944 — Surrogate Endpoint (SUR): Blood pressure
Study 9440666 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 2547916 — Surrogate Endpoint (SUR): Blood pressure
Study 28125624 — Surrogate Endpoint (SUR): Blood pressure
Study 25601978 — Surrogate Endpoint (SUR): Blood pressure
Study 19336728 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 19336728 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 7630982 — Surrogate Endpoint (SUR): Blood pressure
Study 31524770 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 15472858 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17393216 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17393216 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31270173 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 1519166 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 21338187 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study 10958222 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8474315 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 25038306 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25038306 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25038306 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23226979 — Safety Biomarker (SAF): Hyaluronic acid
Study 15551351 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 12046308 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 7878390 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 22117659 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 22117659 — Surrogate Endpoint (SUR): Serum calcium
Study 16775813 — Surrogate Endpoint (SUR): Blood pressure
Study 3147905 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 3147905 — Predictive Biomarker (PRD): PPA1 mRNA
Genes: PPA1; IOPPP; PP
Study 25318481 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 21592879 — Surrogate Endpoint (SUR): Blood pressure
Study 17030755 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 10857171 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 3006619 — Surrogate Endpoint (SUR): Blood pressure
Study 31506396 — Surrogate Endpoint (SUR): Forced vital capacity
Study 15056426 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 11703993 — Surrogate Endpoint (SUR): Blood pressure
Study 22672229 — Surrogate Endpoint (SUR): Serum sodium
Study 21719896 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study 30465917 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 30465917 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study 19124484 — Predictive Biomarker (PRD): Hormone receptor
Study 19124484 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 15482085 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 3033444 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 3033444 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18580254 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study 7720912 — Surrogate Endpoint (SUR): Serum triglycerides
Study 2116441 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 25091659 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 10757465 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10757465 — Surrogate Endpoint (SUR): Blood pressure
Study 1009279 — Surrogate Endpoint (SUR): Blood pressure
Study 28085793 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28085793 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study 25990454 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25990454 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10490157 — Surrogate Endpoint (SUR): Blood pressure
Study 31332027 — Surrogate Endpoint (SUR): Bone mineral density
Study 15071723 — Surrogate Endpoint (SUR): Bone mineral density
Study 31228203 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26272871 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study 26272871 — Predictive Biomarker (PRD): TM6SF2 mRNA
Genes: TM6SF2
Study 15638973 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 18390891 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18390891 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 21843712 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21843712 — Monitoring Biomarker (MOI): Procalcitonin
Study 24453130 — Surrogate Endpoint (SUR): Bone mineral density
Study 21049601 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 17382027 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 17382027 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 11641299 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study 31397943 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 12393737 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 20935337 — Surrogate Endpoint (SUR): Blood pressure
Study 18405787 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18405787 — Safety Biomarker (SAF): 51Cr-EDTA
Study 9661633 — Predictive Biomarker (PRD): SLC5A5 mRNA
Genes: SLC5A5; NIS
Study 9661633 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 29162361 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 26859828 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17319797 — Predictive Biomarker (PRD): CPT1A mRNA
Genes: CPT1A; CPT1
Study 9661544 — Surrogate Endpoint (SUR): Blood pressure
Study 2577460 — Surrogate Endpoint (SUR): Blood pressure
Study 31823063 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 30701400 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 17606328 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 12122965 — Surrogate Endpoint (SUR): Blood pressure
Study 17609908 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 17609908 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 17609908 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 27741007 — Surrogate Endpoint (SUR): Serum calcium
Study 17046377 — Surrogate Endpoint (SUR): Bone mineral density
Study 12894131 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study 29431561 — Predictive Biomarker (PRD): SMPD1 mRNA
Genes: SMPD1; ASM
Study 26826274 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study 20634296 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 20634296 — Surrogate Endpoint (SUR): Serum creatinine
Study 12807386 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 11137977 — Surrogate Endpoint (SUR): Blood pressure
Study 17890954 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 14981602 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 14981602 — Safety Biomarker (SAF): Interleukin 1
Study 8138680 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25216712 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25216712 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 2485043 — Surrogate Endpoint (SUR): Blood pressure
Study 20051299 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 20051299 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 10094243 — Surrogate Endpoint (SUR): Blood pressure
Study 31067706 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 30935897 — Surrogate Endpoint (SUR): Blood pressure
Study 28829155 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 27348483 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 25102686 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study 15786529 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 17352284 — Surrogate Endpoint (SUR): Bone mineral density
Study 29794306 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study 19088352 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9764631 — Surrogate Endpoint (SUR): Bone mineral density
Study 9764631 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 7919326 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7919326 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 3277494 — Surrogate Endpoint (SUR): Blood pressure
Study 31914324 — Predictive Biomarker (PRD): ADRA1D mRNA
Genes: ADRA1D; ADRA1A
Study 23412015 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24660272 — Surrogate Endpoint (SUR): Probing pocket depth
Study 11136787 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11136787 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 2563311 — Surrogate Endpoint (SUR): Blood pressure
Study 2563311 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2563311 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23065000 — Predictive Biomarker (PRD): Hormone receptor
Study 23065000 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 19967563 — Surrogate Endpoint (SUR): Serum calcium
Study 12601621 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8875514 — Safety Biomarker (SAF): Glutamate dehydrogenase
Study 1720487 — Surrogate Endpoint (SUR): Blood pressure
Study 23354927 — Surrogate Endpoint (SUR): Blood pressure
Study 18419878 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 16965691 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 16965691 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 12856155 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 1328365 — Surrogate Endpoint (SUR): Blood pressure
Study 1328365 — Surrogate Endpoint (SUR): Serum triglycerides
Study 24607553 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20206356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20206356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18596318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18596318 — Safety Biomarker (SAF): IL-6 and IL-10
Study 9431859 — Surrogate Endpoint (SUR): Blood pressure
Study 22134839 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 22134839 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study 31571445 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 28255099 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 9247941 — Surrogate Endpoint (SUR): Blood pressure
Study 2881481 — Surrogate Endpoint (SUR): Blood pressure
Study 19924670 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 16380544 — Safety Biomarker (SAF): MTHFR
Study 21263058 — Surrogate Endpoint (SUR): Blood pressure
Study 11895966 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 7872318 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 2205161 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 20601671 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29092879 — Predictive Biomarker (PRD): DMA mRNA
Genes: DMA; HLA-DMA; hCG_2001572
Study 25164513 — Surrogate Endpoint (SUR): Blood pressure
Study 25164513 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23325582 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 23325582 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 23325582 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 23325582 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 23325582 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 23325582 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 23325582 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 7666817 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 15248853 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 15248853 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 15635850 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 30895313 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study 30895313 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 22216509 — Surrogate Endpoint (SUR): Blood pressure
Study 25787041 — Surrogate Endpoint (SUR): Blood pressure
Study 21699786 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 9356529 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8487564 — Surrogate Endpoint (SUR): Blood pressure
Study 12900586 — Surrogate Endpoint (SUR): Blood pressure
Study 12680882 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12680882 — Surrogate Endpoint (SUR): Blood pressure
Study 8735864 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 25800756 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study 29461600 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29461600 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 27475262 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 24052631 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 6405773 — Surrogate Endpoint (SUR): Blood pressure
Study 25555562 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 25555562 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 21121927 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 31805134 — Predictive Biomarker (PRD): PCSK5 mRNA
Genes: PCSK5; PC5; PC6
Study 20016796 — Surrogate Endpoint (SUR): Blood pressure
Study 10221439 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7491855 — Surrogate Endpoint (SUR): Blood pressure
Study 31409556 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 31409556 — Predictive Biomarker (PRD): CX3CL1 mRNA
Genes: CX3CL1; FKN; NTT; SCYD1; A-152E5.2
Study 31409556 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 28698175 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16939514 — Predictive Biomarker (PRD): TRERF1 mRNA
Genes: TRERF1; BCAR2; RAPA; TREP132
Study 16939514 — Surrogate Endpoint (SUR): Serum creatinine
Study 2161435 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2161435 — Surrogate Endpoint (SUR): Blood pressure
Study 28442424 — Predictive Biomarker (PRD): TXN mRNA
Genes: TXN; TRDX; TRX; TRX1
Study 25655102 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 23551856 — Surrogate Endpoint (SUR): Bone mineral density
Study 12505865 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 12505865 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 12505865 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12505865 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 28936 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study 15180757 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 7640969 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study 29747087 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 29747087 — Predictive Biomarker (PRD): ABCA1 mRNA
Genes: ABCA1; ABC1; CERP
Study 19635613 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 8302148 — Surrogate Endpoint (SUR): Blood pressure
Study 10361382 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 25150117 — Surrogate Endpoint (SUR): Serum creatinine
Study 19848199 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 9424404 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 2972170 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 16871743 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 16871743 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 16871743 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 26011507 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 23257347 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 23257347 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 15886245 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 15886245 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 10081536 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 7593729 — Surrogate Endpoint (SUR): Blood pressure
Study 24104699 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 22449319 — Surrogate Endpoint (SUR): Blood pressure
Study 21094362 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21094362 — Surrogate Endpoint (SUR): Blood pressure
Study 10907671 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 1418829 — Surrogate Endpoint (SUR): Blood pressure
Study 1418829 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 27207107 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 12623851 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study 12623851 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10599980 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30584292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26960786 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 19854729 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7117676 — Surrogate Endpoint (SUR): Blood pressure
Study 31731368 — Monitoring Biomarker (MOI): HBV DNA
Study 31731368 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 31731368 — Surrogate Endpoint (SUR): Serum phosphate
Study 31731368 — Surrogate Endpoint (SUR): Serum creatinine
Study 27490918 — Surrogate Endpoint (SUR): Serum triglycerides
Study 22813645 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21140357 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 21140357 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 21140357 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15501923 — Surrogate Endpoint (SUR): Blood pressure
Study 11896120 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study 8116715 — Surrogate Endpoint (SUR): Blood pressure
Study 30431499 — Surrogate Endpoint (SUR): Blood pressure
Study 12074253 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 19356621 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 19356621 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG